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doi:10.1016/j.ejvs.2010.08.015Abstract Background: It is commonly reported that chronic venous disease (CVD) increases
the skin iron content in which the excess is stored as haemosiderin. Despite increasing interest
in the role of haemosiderin in venous ulceration, no study has systematically evaluated the
occurrence of iron overload in the limbs of patients with CVD.
Purpose: To evaluate skin haemosiderin deposition in relation to the presence and severity of
skin changes in CVD legs designated according to the clinical, etiologic, anatomic and patho-
physiologic (CEAP) classification.
Methods: A total of 85 skin biopsies were taken from the medial aspect of 49 limbs with CVD of
CEAP clinical stages C2, C3, C4 and C6. The content of ferric ions was assessed by Perl’s Prus-
sian Blue (PPB) stain.
Results: No haemosiderin deposition was found in normal skin of C2, C3 and C4A legs, in less
severe regions of pigmentation and in some parts of more severely affected limbs. Haemo-
siderin was always present in lipodermatosclerotic skin and ulcers. Occasionally, haemosi-
derin was found in the apparently normal perilesional skin of C4b and C6 legs. The
regenerating dermis at the base of healing ulcers showed none or light haemosiderin depo-
sition.
Conclusion: Iron overload is not present in the less severe stages of skin damage due to CVD
but lipodermatosclerosis and leg ulcers are always accompanied by haemosiderin deposition.
In fact, no severe skin changes occur in CVD legs until iron overload occurs. Our results are in
agreement with previous reports suggesting that a genetic inability to counteract skin iron.D., Department of Anatomy, University ‘La Sapienza’, Via Borelli 50, 00161, Rome, Italy. Tel.: þ39
niroma1.it (A. Caggiati).
ty for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
778 A. Caggiati et al.Table 1 Exclusion criteria.
1) Arterial diseases, lymphatic
vasculitis, collagen disease).
2) Dermatological disorders.
3) Haematological diseases, ca
4) Any previous surgical treatm
5) History or current administroverload is present in these patients. A more detailed analysis of disordered iron metabolism
should be undertaken in CVD patients.
ª 2010 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Legs afflicted with chronic venous disease (CVD) may
undergo skin changes ranging from small spot-like pigmen-
tation to large ulcers.1 According to the clinical, etiologic,
anatomic and pathophysiologic (CEAP) classification, the
presence of skin lesions characterises the severity of CVD.1
Although a number of cellular and molecular mediators,
biochemical mechanisms and structural changes have been
described in detail,2 the exact pathogenesis of stasis
dermatitis is still not completely understood. However, all
current studies agree that skin changes are due to an
inflammatory process triggered by venular hypertension.3
An increased content of iron in the skin of CVD legswas first
reported in 1965 by Myers4 and is currently explained by
extravasation and disruption of erythrocytes, followed by
decomposition of haemoglobin. The resulting excessive tissue
iron (Feþþþ, ferric ions) is stored as haemosiderin. The
abnormal presence of this compound in the skin of CVD legs
has been demonstrated by Perl’s Prussian Blue stain (PPB).5e7
Haemosiderin is currently considered to be the cause of
the brownish skin pigmentation typical of CVD.4,8 An
increasing interest in the role of haemosiderin in the
pathogenesis of venous disease followed the demonstration
of either the pro-inflammatory properties of ferric ions,9,10
and the link between venous ulcer and genetical disorders
of iron metabolism.10,11 Despite these important data, no
study has systematically evaluated haemosiderin accumu-
lation in relation to the presence and severity of skin
changes.
To contribute to an understanding of the effective role
of ferric ions in the pathogenesis of CVD-related skin
changes and ulcer development, we have morphometrically
evaluated haemosiderin deposition in skin samples from
legs afflicted with CVD at different clinical stages of the
CEAP classification.Patients, Materials and Methods
A total of 44 Caucasian patients in whom clinical investi-
gation and duplex ultrasonography demonstrated the
presence of CVD8 were included in this study. The severity
of CVD in each leg was assigned to the appropriate CEAP
clinical class by a physician skilled in the management ofdisorders, microangiopathies (d
rdiac, pulmonary, renal or hepa
ent, trauma or irradiation of t
ation of drugs known to affectvenous disease.1 The severity of pigmentation was scored
according to the Venous Clinical Severity Score (VCSS).12
History or evidence of morbidities or treatments possibly
influencing skin changes and metabolism were considered
to be exclusion criteria (Table 1). The local ethics
committee approved this study and all patients gave
informed written consent to their inclusion in this research.
As many as 85 skin biopsies were taken from the medial
aspect of 49 legs with CVD (C2: 16 legs; C3: four legs; C4A:
12 legs; C4B: 10 legs; C6: seven legs) in 44 patients (20 men,
24 women; mean age 62 years). A total of 49 biopsies were
from apparently normal skin, 12 were from pigmented
lesions (seven scored 1e2 by VCSS; five scored 3), 10 were
taken from skin areas with lipodermatosclerosis (LDS) and
14 were from open ulcers. No samples were obtained from
C5 legs (Table 2).
In C2, C3 and C4 legs, punch biopsies (2e4 mm) were
obtained mostly during surgery for varicose veins (the
resulting holes were then used to perform avulsion of
varicosities). Specimens from C6 legs were also obtained
during ulcer debridement or skin grafting. All biopsies
included the whole dermis and at least a thin layer of
subcutaneous tissue.
All legs with skin changes (pigmentation, LDS or ulcer)
underwent at least two biopsies, one from the affected skin
and one from the adjacent apparently normal skin. In C6
legs, ulcer tissues were taken from both the wound edge
and ulcer bed. Finally, four skin biopsies were taken from
the medial aspect of the leg in four subjects (two male, two
female; mean age 57.7 years) in whom there was no clinical
or duplex evidence of CVD. These patients were undergoing
orthopaedic surgery. Skin biopsies were fixed in 10% buff-
ered formalin solution and routinely processed for haema-
toxylin/eosin (HE) and PPB stains. This technique is able to
demonstrate the presence of haemosiderin in the dermis as
has been previously demonstrated.5e7,11
Quantitative measurements of haemosiderin deposition
wereperformedondigital images capturedby theD-Sight Fluo
microscope (Menarini, Italy). PPB stain positive areas were
objectively quantified using the D-Sight Viewer package
(Menarini, Italy)where themarginof the tissuewas tracedand
the area containing haemosiderin was defined as the Area of
Interest (AoI). This resulted in colour segmentation expressediabetes, rheumatoid arthritis,
tic failure.
he leg.
iron metabolism and skin trophism
Table 2 Designation of samples according to C-Class.
C-Class C2 C3 C4A C4B C6 Total
Number of legs 16 4 12 10 7 49
Number of biopsies 16 4 24 20 21 85
Skin Iron Deposition During CVD 779as percentage of AoI. Data were finally transferred into an
Excel (Microsoft) spreadsheet for further analysis.
The mean value of AoI and standard deviation (SD) were
calculated in PPB þ specimens grouped according to the
CEAP-Class of the donor leg. Due to the small sample size,
these values were compared by using ManneWhitney test.
A p-value < 0.05 was regarded as significant. Bonferroni’s
correction was applied to control the possibility of a type I
error.
Results
Haemosiderin was visible as granules (siderosomes), which
appeared brownish or black in HE sections and blue in PPB
sections (Fig. 1). Siderosomes were found within dermal
macrophages (siderophages) (Fig. 1(A)) as well as in the
interstitium between the collagen bundles of the dermis
(Fig. 1(B)). In case of more intense haemosiderin deposi-
tion, PPB stained diffusely the dermis (Fig. 1(C)) and even
the stroma of the subcutaneous layer (Fig. 2(D)). The
prevalence of PPB þ specimens and the mean values of AoI
are reported in Table 3.
Control legs: All samples from control legs were nega-
tive for haemosiderin deposition (AoI Z 0%).
Apparently normal skin from CVD legs: No haemosiderin
was found in most (46/49) biopsies taken from apparentlyFigure 1 Skin biopsies from medial face of CVD legs. A) Granules
(HE, original magnification 20). B) Siderosomes may be found
(HE, original magnification 20). C) Border of an active ulcer. In
interstitial spaces. (PPB, original magnification 20).normal skin. The only exceptions were two samples taken
from C4B legs in proximity of a lipodermatosclerotic plaque
(AoIZ 1.6 and 9.6, mean 5.6, SD 5.7) and one from a C6 leg
taken close to the border of an active ulcer (AoI Z 2.8%).
Pigmented skin: Haemosiderin was absent in all biopsies
involving mild-to-moderate pigmentation (scored 1e2 by
VCSS). It was found in only three out of five biopsies taken
from severe pigmentations that scored 3 by VCSS (mean
AoI Z 10.3%, SD 11.4).
Lipodermatosclerotic skin: All these biopsies showed
severe haemosiderin deposition in the dermis (Fig. 2(C))
and even in the subcutaneous layer (Fig. 2(D)) (mean
AoI Z 45%, SD 9.0).
Specimens from ulcerated skin: Specimens from ulcer
tissues showed haemosiderin deposition (mean AoI of 28, SD
9.5) (Fig. 1(C)). No significant differences were seen
between specimens from wound edge and bed (mean AoI:
28, SD 9.3 and 25  17, respectively). In two ulcers, which
showed reparative phenomena (Fig. 3), the regenerating
dermis at the wound bed was nearly completely devoid of
haemosiderin (AoI: 0% and 7.4%, respectively).
Statistical evaluation
A ManneWhitney U test with Bonferroni’s correction
demonstrated that haemosiderin deposition wasof haemosiderin (siderosomes) are visible within macrophages
also in the interstitial spaces between dermal fibroblasts.
presence of excessive iron overload, PPB diffusely stains the
Figure 2 Differences in the intensity of haemosiderin deposition in skin biopsies from medial face of CVI-legs. A) Absence of
haemosiderin deposition (PPB, original magnification 20). B) Light haemosiderin deposition. This specimen belonged to a biopsy of
apparently normal skin taken at the border of an LDS area (PPB, original magnification 20). C) Biopsy of LDS skin (PPB, original
magnification 20). D) Haemosiderin deposition extending to the subcutaneous layer (PPB, original magnification 20).
780 A. Caggiati et al.significantly higher in lipodermatosclerotic skin if compared
with samples from heavily pigmented skin (p < 0.01) and
ulcer tissues (p < 0.01).Discussion
Iron is normally present in the skin because about 20e25%
of absorbed iron is daily eliminated by exfoliation of
epidermal cells.13 As a protection against its toxicity, iron is
sequestered in iron-binding or haeme-containing proteins
(ferritin and haemosiderin, respectively). Haemosiderin is
currently considered the histological marker of tissue iron
excess.7,13
In the past, skin iron overload was demonstrated in CVD
legs by PPB,6,7 X-ray spectrometry14 and atomic absorption
spectrum analysis.9 However, most of these investigations
considered ulcerated legs. The present study is thus the
first to have systematically evaluated skin haemosiderin
deposition in legs at any stage of severity of CVD. The main
findings can be summarised as follows:
No haemosiderin deposition was found in the normal skin
of C2, C3 and C4A legs, in less severe pigmentation and in
part of more severe ones. By contrast, haemosiderin was
always present in lipodermatosclerotic skin and active
ulcers. Occasionally, haemosiderin was found in the
apparently normal perilesional skin of C4b and C6 legs.Table 3 Prevalence of PPB-positive samples and intensity of ha
both C-class of the donor leg and clinical appearance of the skin
C Class C2 C3 C4
Apparently normal skin 0/16(0%) 0/4 (0%) 0/1
Pigmentations þ/þþ e e 0/7
Pigmentations þþþ e e 3/5
Lipodermatosclerotic e e e
Ulcer edge e e e
Ulcer bed e e eThese results indicate that haemosiderin deposition does
not intervene in the initial phases of stasis dermatitis. In
turn, PPB-positive ferric overload accompanies the wors-
ening of skin damage and, from the histological point of
view, it characterises LDS and ulcers. Iron loss due to ulcer
secretion6 could explain why iron content in ulcer samples
is lower than in LDS skin.
The regenerating dermis at the base of two healing
ulcers showed none or very light haemosiderin deposition.
This agrees with previous studies, which demonstrated
that iron levels decrease when venous ulcer heals.5e7
Unfortunately, biopsies of healing or healed ulcers are
difficult to obtain due to ethical implications. We could
only hypothesise that reduction of PPB staining might
correlate with ulcer healing.
Iron is a well-known mediator of skin toxicity in a variety
of pathological conditions including sunburn,15 porphyria
cutanea tarda,16 inflammation17 and even skin cancer.18 In
CVD legs, it has been demonstrated that ferric ions con-
tained in haemosiderin intervene in the pathogenic chain
leading to matrix disruption and ulcer development by
generation of free radicals,6,9 activation of metal-
loproteinase19 or, finally, down-regulation of tissue inhibi-
tors of metalloproteinase.9,20,21 Our findings do not explain
the exact iron-derived mechanism of skin damage but
clearly demonstrate that severe skin changes and tissue
iron overload are highly correlated.emosiderin deposition. Samples are designated according to
where biopsies were taken. Mean AoI between brackets.
A C4B C6 Total
2 (0%) 2/10 (5.6%) 1/7 (2.8%) 49
(0%) e e 7
(10.3%) e e 5
10/10 (45.0%) e 10
e 6/7 (28.0%) 7
e 7/7 (25.4%) 7
Figure 3 A) 38 years old male, left leg. B) Note the great deposition of haemosiderin in the ulcer border (PPB, original
magnification 20). C) Haemosiderin is nearly completely absent in the regenerating epithelium of the ulcer base (PPB, original
magnification 20).
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present for many years without any ulcer or bronzing of
the skin.”.22 In medical practice, it is a common finding to
see legs with severe and long-lasting CVD and normal skin
or, by contrast, young subjects with heavy pigmentation
and even LDS or ulcer (Fig. 3). Similarly, skin iron overload
correlates with the entity of skin changes but not with the
duration and severity of CVD. It is evident that impairment
of venous haemodynamic is “.an essential but insufficient
factor in explaining subsequent skin changes.”.11
Our findings suggest that patients with LDS or ulcer are
unable to counteract CVD-induced skin iron overload. It has
been hypothesised that such inability could be genetically
determined.23 This has been demonstrated in other cuta-
neous pigmentation diseases such as porphyria cutanea
tarda24 and explains why cutaneous siderosis occurs in only
about one-half of patients with haemochromatosis.25,26
Recently, a strong genetic component in the pathogenesis
of ulcer has been reported.19,27 In particular, a positive
correlation has been demonstrated between susceptibility,
healing time and size of venous ulceration with mutations of
genes involved in iron metabolism.19 If these mutations are
currently considered asymptomatic for systemic diseases, in
combination with an acquired condition (venular hyperten-
sion) they could be responsible of LDS and ulcer.23
The weaknesses of this study include the fact that few
biopsies were taken from healing ulcers and none from C5legs due to ethics committee restrictions. These limited the
extent of this research. We have so far not performed
genetic investigation to assess iron metabolisms disorders
in these patients.
In conclusion, our findings indicate that haemosiderin
does not intervene in the initial phases of skin changes in
venous disease and that its deposition appears to be
obligatory when severe skin changes and ulceration
develop. Our results are in agreement with previous reports
suggesting a genetic inability to counteract skin iron over-
load. Considering that at least 10% of Caucasians are
carriers of iron metabolism disorders,28,29 it is desirable
that genetic investigation should be included in the clinical
evaluation of patients with CVD.19,27 This could help clini-
cians to identify leg ulcers that require advanced wound-
healing treatment or surgery, in conjunction with
compression therapy.
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